[ad_1]
A UMCG research group is working on a new treatment for people with Sjögren's Syndrome, suffering from rheumatic disease. For this, she will receive four hundred thousand euros from Rheumatology Netherlands and an appointment as a research center of excellence.
This is a new treatment that will restore the function of the salivary glands of people with Sjögren's syndrome. Fractured saliva and lacrimal glands due to inflammation are still common and due to the disease.
Breakthroughs that improve life with [Sjögren
Prof. dr. Dr. Frans Kroese, Senior Researcher of the UMCG Research Group, is proud of his appointment as a Center for Excellence Research. "With this research, we gain a better understanding of what is happening with the salivary glands of patients with Sjögren's syndrome.We believe that we can help the recovery capacity by making additional salivary stem cells and by returning them to Patients ', says Kroese,' Our research is really about teamwork and this recognition pays tribute to the joint efforts of many people to make a breakthrough. with Sjögren's Syndrome. "
About Sjögren's Syndrome
Sjogren's syndrome is one of the forms of inflammatory rheumatism . Inflammatory rheumatism is a collective name for various autoimmune diseases that severely damage joints, muscles and organs.
The immune system makes a mistake in inflammatory rheumatism: joints, muscles and healthy organs are attacked unfairly. The immune response also derails: inflammations continue to increase, with disastrous consequences.
In people with Sjögren's syndrome, saliva and lacrimal glands break through inflammation. For example, an extremely dry mouth poses major problems of food and swallowing. In addition, the lungs, kidneys and nervous system can be seriously affected.
Lodewijk Ridderbos, director of Rheumatology in the Netherlands, expects the research group to propose breakthrough discoveries that will be a major breakthrough in the treatment of patients with Sjogren's syndrome. Ridderbos: "UMCG has unique expertise in the use of stem cells.We had not thought that it was possible to treat Sjögren with stem cell therapy until recently." Now, ReumaNederland wants to do everything to make this a reality. "
In addition to the appointment of the research group in Groningen and its four hundred thousand euros, Rheumatium Netherlands will release an additional 7.3 million euros for funding. further research in the Netherlands over the next five years.
[ad_2]
Source link
